REAL-WORLD EFFECTIVENESS OF SOFOSBUVIR / VELPATASVIR/VOXILAPREVIR AS A HEPATITIS C VIRUS INFECTION SALVAGE TREATMENT

被引：0
|
作者：
Krajden, Mel [1 ]
Cook, Darrel [2 ]
Wong, Stanley [2 ]
Wilton, James [2 ]
Butt, Zahid Ahmad [3 ]
Bartlett, Sofia [2 ]
Pearce, Margo [2 ]
Ramji, Alnoor [4 ]
Yoshida, Eric M. [5 ]
Yu, Amanda [2 ]
Alvarez, Maria Jose [2 ]
Binka, Mawuena [3 ]
Janjua, Naveed [2 ,6 ]
机构：
[1] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC, Canada
[2] British Columbia Ctr Dis Control, Vancouver, BC, Canada
[3] Univ British Columbia, Vancouver, BC, Canada
[4] Univ British Columbia, Med, Vancouver, BC, Canada
[5] Univ British Columbia, Div Gastroenterol, Vancouver, BC, Canada
[6] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC, Canada
来源：
HEPATOLOGY | 2019年 / 70卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1519
引用
收藏
页码：914A / 914A
页数：1
相关论文
共 50 条
  • [21] Real-world effectiveness and safety of sofosbuvir/velpatasvir and ledipasvir/ sofosbuvir hepatitis C treatment in a single centre in Germany
    Buggisch, Peter
    Wursthorn, Karsten
    Stoehr, Albrecht
    Atanasov, Petar K.
    Supiot, Romain
    Lee, Janet
    Ting, Jie
    Petersen, Joerg
    PLOS ONE, 2019, 14 (04):
  • [22] Real-life effectiveness of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients previously treated with sofosbuvir/velpatasvir or glecaprevir/pibrentasvir
    Ruiz-Cobo, Juan Carlos
    Llaneras, Jordi
    Forns, Xavier
    Gallego Moya, Adolfo
    Conde Amiel, Isabel
    Arencibia, Ana
    Diago, Moises
    Garcia-Samaniego, Javier
    Castellote, Jose
    Llerena, Susana
    Rodriguez-Seguel, Elisa
    Mateos, Beatriz
    Rodriguez, Manuel
    Rosales Zabal, Jose Miguel
    Fernandez, Inmaculada
    Calleja, Jose Luis
    Morillas, Rosa Maria
    Montoliu, Silvia
    Andrade, Raul J.
    Badia Aranda, Ester
    Hernandez-Guerra, Manuel
    Mate, Carlota Jimeno
    Gonzalez-Santiago, Jesus M.
    de Cuenca, Beatriz
    Bernal-Monterde, Vanesa
    Delgado, Manuel
    Turnes, Juan
    Lens, Sabela
    Buti, Maria
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2024, 60 (02) : 201 - 211
  • [23] Real-life effectiveness of voxilaprevir/sofosbuvir/velpatasvir in hepatitis C patients previously treated with sofosbuvir/velpatasvir or glecaprevir/pibrentasvir
    Ruiz-Cobo, Juan Carlos
    Llaneras, Jordi
    Buti, Maria
    Forns, Xavier
    Conde, Isabel
    Arencibia Almeida, Ana
    Diago, Moises
    Garcia-Samaniego Rey, Francisco Javier
    Castellote Alonso, Jose
    Llerena, Susana
    Rodriguez, Elisa
    Mateos Munoz, Beatriz
    Rodriguez, Manuel
    Fernandez Vazquez, Inmaculada
    Rosales Zabal, Jose Miguel
    Calleja Panero, Jose Luis
    Morillas, Rosa M.
    Montoliu, Silvia
    Gallego Moya, Adolfo
    Andrade, Raul J.
    Hernandez Guerra, Manuel
    Badia-Aranda, Esther
    Jimeno Mate, Carlota
    Gonzalez Santiago, Jesus
    Cuenca, Beatriz
    Bernal Monterde, Vanesa
    Delgado, Manuel
    Turnes, Juan
    Lens, Sabela
    JOURNAL OF HEPATOLOGY, 2023, 78 : S1205 - S1206
  • [24] SAFETY AND EFFICACY OF SOFOSBUVIR/VELPATASVIR/VOXILAPREVIR IN ADOLESCENTS WITH CHRONIC HEPATITIS C VIRUS INFECTION
    Bansal, Sanjay
    Pawlowska, Malgorzata
    Nebbia, Gabriela
    Di Dato, Fabiola
    Sluzewski, Wojciech
    Giacomet, Vania
    Szenborn, Leszek
    Shao, Jiang
    Yue, Mun Sang
    Hsueh, Chia-Hsiang
    Parhy, Bandita
    Gaggar, Anuj
    Kersey, Kathryn
    Mangia, Alessandra
    Kelly, Deirdre
    Indolfi, Giuseppe
    HEPATOLOGY, 2020, 72 : 571A - 571A
  • [25] Sofosbuvir, velpatasvir and voxilaprevir combination therapy for treating patients with hepatitis C virus infection
    Summers, B. B.
    DRUGS OF TODAY, 2018, 54 (04) : 255 - 268
  • [26] Non-responders to sofosbuvir/velpatasvir/voxilaprevir in the treatment of chronic hepatitis C infection
    Karimi-Sari, Hamidreza
    Rezaee-Zavareh, Mohammad Saeid
    Falade-Nwulia, Oluwaseun
    Lim, Joseph K.
    JOURNAL OF HEPATOLOGY, 2022, 77 (04) : 1215 - 1217
  • [27] Real-world effectiveness of daclatasvir plus sofosbuvir and velpatasvir/sofosbuvir in hepatitis C genotype 2 and 3
    Belperio, Pamela S.
    Shahoumian, Troy A.
    Loomis, Timothy P.
    Mole, Larry A.
    Backus, Lisa I.
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : 15 - 23
  • [28] Sofosbuvir/velpatasvir/voxilaprevir for hepatitis C virus retreatment in decompensated cirrhosis
    Patel, Sonalie
    Martin, Michelle T.
    Flamm, Steven L.
    LIVER INTERNATIONAL, 2021, 41 (12) : 3024 - 3027
  • [29] Sofosbuvir-velpatasvir and sofosbuvir-velpatasvir- voxilaprevir: novel treatment options for naive and previously treated hepatitis C infection
    Shin, Hyun Phil
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2023, 38 (04): : 454 - 455
  • [30] Sofosbuvir/Velpatasvir/Voxilaprevir: A Review in Chronic Hepatitis C
    Young-A Heo
    Emma D. Deeks
    Drugs, 2018, 78 : 577 - 587
12345